Moreover, AXL and the other TAM receptors (TYRO3 and MERTK) have been reported as key mediator of chemoresistance in neuroblastoma through induction of EMT and in lung cancer through the regulation of mitogen-activated protein kinase (MAPK) and FAS signaling pathways (40). Here, MERTK is linked to neuroblastoma.